![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 11, 2006 12:11:26 AM
The references in the article to "require the Company to license the patents" and "the judge will have to set a rate for future sales" are the same thing.
As to your other question, I can't imagine the judge setting the royalty rate so low that insmed would elect not to file an appeal. Based on Insmed's post verdict conference call the royalty would be required on future indications using the same manufacturing process and the royalty would remain in place to the extent any of the three patents have not expired (the 414 expires last in 2018). Exactly how low could that royalty possibly be to warrant not pursuing the alternative which is to appeal and possibly eliminate the royalties altogether? IMHO there is absolutely no chance that Insmed will NOT file an appeal.
The Inequitable conduct only directly affects the 151 patent, so the key is still to file an appeal in order to attempt to invalidate the 414 patent which reduces any royalty to a maximum 3-4 year period (287 & 151 patents both expire in 2010).
The keys as I see it right now in my order of priority are:
1. Judge Wilkins' ruling on the inequitable conduct motion related to the 151 patent(this may have some immediate bearing on verdict/mistrial, timing of the filing for an appeal, and royalty rate).
2. Judge Wilkens' decision regarding granting injunctive relief. Her opinion in some way may be influenced by outcome in #1 above.
3. Judge Wilkens' decision on a royalty rate for future sales (post verdict) assuming she does not grant injunctive relief.
4. Financing/Partner in EU announcements. I would like this as a higher priority on my list, but can not imagine a partnering announcement taking place prior to Judge's decision on injunctive relief.
5. Requirements that may be placed on insmed to set aside the cash for the $7.5 million up front payment and the royalty amount on PAST sales that would make this cash unavailable for operations and thus may result in the need for cash a little sooner. The set aside of the cash may be a court ordered requirement to place it in an escrow account or a requirement of Generally Accepted Accounting Principles (GAAP).
6. Filing of an appeal with the US Court of Appeals for the Federal Circuit with the objective of winning in all regards, but at minimum to get the 414 patent invalidated. This appeal is a given! Whether Insmed files it now or two months from now after the hearing on Feb 16th, 2007 is not a major issue to me.
Recent INSM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 09:19:37 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 07/05/2024 12:00:00 PM
- Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference • PR Newswire (US) • 07/03/2024 01:03:00 PM
- Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025 • PR Newswire (US) • 06/27/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 12:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:21:15 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 06/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:23:25 PM
- Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:00:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 08:33:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:46:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:44:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:41:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 09:32:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/30/2024 08:15:33 PM
- Insmed to Host Commercial Webinar on June 4, 2024 • PR Newswire (US) • 05/30/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/30/2024 08:02:27 PM
- Insmed Announces Pricing of $650 Million Public Offering of Common Stock • PR Newswire (US) • 05/30/2024 12:00:00 PM
- Insmed Announces Proposed $500 Million Public Offering of Common Stock • PR Newswire (US) • 05/28/2024 10:21:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:51:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:49:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:47:36 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM